Cite

HARVARD Citation

    Tinahones, F. et al. (2018). Alirocumab efficacy and safety by body mass index: Pooled analysis from 10 Phase 3 ODYSSEY trials. Atherosclerosis. pp. e53-e54. [Online]. 
  
Back to record